Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

Condition:   Inclusion Body Myositis Intervention:   Drug: Arimoclomol Sponsor:   Orphazyme Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials